Upon the development of primary AML, we transplanted 5,000 AML cells into recipient mice and treated them with either saline or polyinosinic:polycytidylic acid (poly(I:C)) to induce Cre (hereafter referred to as Impdh2 KO). The gene discussed is IMPDH2; the disease is acute myeloid leukemia.